TY  - JOUR
AU  - Cabezas-Camarero, Santiago
AU  - Cabrera Martín, María Nieves
AU  - Merino Menéndez, Salome
AU  - Paz-Cabezas, Mateo
AU  - García-Barberán, Vanesa
AU  - Saiz-Pardo Sanz, Melchor
AU  - Iglesias Moreno, María Cruz
AU  - Alonso-Ovies, Almudena
AU  - Pérez Segura, Pedro
PY  - 2021
DO  - 10.1002/onco.13754
SN  - 1083-7159
UR  - https://hdl.handle.net/20.500.14352/115152
T2  - The oncologist.
AB  - Background: There are still few data on the activity and safety of cetuximab-based salvage chemotherapy after immunotherapy (SCAI) in patients with squamous cell cancer of the head and neck (SCCHN).Materials and methods: This was a retrospective study...
LA  - eng
M2  - e1018
PB  - 2022- : Oxford : Oxford University Press
KW  - Cetuximab
KW  - Head and neck cancer
KW  - Immunotherapy
KW  - PD-1/PD-L1 inhibitors
KW  - Salvage chemotherapy
TI  - Safety and Efficacy of Cetuximab-Based Salvage Chemotherapy After Checkpoint Inhibitors in Head and Neck Cancer
TY  - journal article
VL  - 26
ER  -